Minimally invasive mitral valve repair with creation of artificial chordae tendonae for mitral regurgitation. European reimbursement report
Report presents summary of the reimbursement situation for a specific minimally invasive mitral valve repair procedure with creation of artificial cordae tendonae. The technology is intended to support natural chordae tendonae, when it is ruptured or elongated as a consequence of the degenerative valve disease. The report explores reimbursement situations for procedure in 11 European countries: Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. The report includes information about reimbursement systems for medical devices, procedure coding for target procedure, diagnosis coding, payment mechanisms, reimbursement tariffs, policy considerations by payers and policy-makers as well as restrictions on indications or scenarios for use of target procedure.